safety of medications
biological data
prescribed medications
richness of data
research proposal
fetal safety
specific medications results
development of neurodevelopmental disorders
risks of neurodevelopmental disorders
large population-based birth cohort
National Prescription Data Base
Medical Birth Registry
new field
new knowledge
new horizons
future research
Pregnancy
fetal exposure
changes
recent availability of large scale human data
current understanding of safety pharmacology
mother-child pairs
developing unborn child
Effects of Medication Use
Infant Neurodevelopment
unique opportunity
project unique
understanding of origins
genome-wide mapping of DNA methylation
Norwegian Patient Registry
existence of biological material
effect of prenatal exposure
possibility of register linkages
affordable costs
young children
psychotropics
analgesics
epigenetic events
range of methodological approaches
thousands of pregnant women
nationwide registries
opportunities
study
innovative pharmaceutical insight
unrecognized role
pregnancies
causal inference
pharmaco-epigenetics
final outcome
sufficient information
childhood
size
offspring